Burning Rock Biotech Ltd

Healthcare · Diagnostics & Research

15.80$ -2.6% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Burning Rock Biotech Ltd (BNR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 751 million CNY. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Balance Sheet BNR
Line item	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	373	–	–	899	848	1,069	2,942	2,802	2,663	2,682	2,540	2,426	2,279	2,108	1,861	1,731	1,587	1,417	1,331	1,167	1,040	985	1,023	985	885	855	825	812	821	788	751
Current Assets	293	136	–	800	707	932	2,793	2,647	2,524	2,410	2,217	1,993	1,821	1,685	1,463	1,355	1,259	1,139	1,090	967	884	841	806	785	777	762	741	739	739	701	659
Cash	93	-136	–	124	94	364	2,566	2,062	1,895	2,085	1,853	1,622	1,431	1,266	1,149	1,010	905	793	733	636	615	573	533	498	520	495	453	464	481	446	419
Cash & Short-Term Investments	136	136	–	516	408	682	2,566	2,402	2,257	2,121	1,888	1,657	1,495	1,329	1,149	1,010	905	793	733	636	615	573	533	498	–	495	453	464	481	446	419
Receivables	36	–	–	87	90	95	101	114	111	101	106	130	161	148	146	149	170	174	202	199	150	158	174	184	152	177	205	197	182	177	183
Inventory	49	–	–	55	58	60	67	70	68	98	114	116	123	130	130	150	130	114	102	87	69	63	66	66	54	65	58	54	57	54	34
Property, Plant & Equipment	–	–	–	–	–	84	91	97	111	245	288	383	406	395	368	347	300	260	222	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.8	1.8	1.8	–	–	–	–	–	–	–	–	–	–	0.3	0.3	–
Intangible Assets	0.5	–	–	0.4	0.3	0.3	0.2	3.5	3.5	3.4	4.9	4.2	5.2	4.2	3.4	2.8	0.2	1.7	1.2	1.3	1.0	0.7	0.7	0.5	0.4	0.4	0.4	0.3	0.3	0.3	0.2
Total Liabilities	380	–	–	167	1,739	181	259	270	242	349	366	365	433	453	429	432	429	372	363	304	272	268	346	337	304	283	261	263	285	271	254
Current Liabilities	285	–	–	147	164	143	224	269	242	275	303	307	372	400	359	363	411	358	353	295	263	255	260	258	266	252	230	235	247	230	218
Short-Term Debt	176	–	–	51	44	33	22	45	47	73	72	44	37	38	40	39	37	32	23	14	8.6	11	27	28	–	23	19	17	17	21	21
Accounts Payable	2.4	–	–	1.5	12	16	27	30	35	50	48	49	63	98	56	71	51	24	25	24	18	25	26	25	34	36	32	34	41	18	18
Long-Term Debt	–	–	–	–	18	33	32	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.8	1.8	1.7	1.7	–
Shareholders' Equity	-7.3	-7.3	–	731	-891	888	2,683	2,533	2,421	2,334	2,173	2,061	1,845	1,655	1,432	1,299	1,158	1,046	968	863	768	717	678	648	581	572	564	550	536	516	497
Retained Earnings	-612	–	–	-812	-946	-1,025	-1,135	-1,262	-1,418	-1,603	-1,807	-1,978	-2,229	-2,490	-2,752	-2,984	-3,200	-3,385	-3,516	-3,691	-3,854	-3,975	-4,083	-4,119	-4,200	-4,214	-4,223	-4,240	-4,258	-4,273	-4,293
Shares Outstanding	0.2	0.2	0.2	0.2	0.2	0.3	0.4	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	108	1.1	1.1	1.1	1.0	1.1	1.1

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings